Cases 11 - 20 of 27
Exela Pharma Sciences, LLC v. Hikma Pharmaceuticals USA Inc.
as 1:2023cv00137
Plaintiff:
Exela Pharma Sciences, LLC
Defendant:
Nivagen Pharmaceuticals, Inc. and Hikma Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Hikma Pharmaceuticals USA Inc. et al v. Annora Pharma Private Limited
as 1:2023cv00231
Plaintiff:
Hikma Pharmaceuticals USA Inc. and Hikma International Pharmaceuticals LLC
Defendant:
Annora Pharma Private Limited
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.
as 23-1169
Plaintiff / Appellant:
AMARIN PHARMA, INC., AMARIN PHARMACEUTICALS IRELAND LIMITED and MOCHIDA PHARMACEUTICAL CO., LTD.
Defendant / Appellee:
HIKMA PHARMACEUTICALS USA INC., HIKMA PHARMACEUTICALS PLC and HEALTH NET LLC
Novo Nordisk Inc. et al v. Hikma Pharmaceuticals USA Inc.
as 1:2021cv01783
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Hikma Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
InfoRLife SA et al v. Hikma Pharmaceuticals USA Inc.
as 1:2021cv01764
Plaintiff:
InfoRLife SA and WG Critical Care, LLC
Defendant:
Hikma Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271
Astellas US LLC et al v. Hikma Pharmaceuticals USA, Inc.
as 1:2021cv01785
Plaintiff:
Astellas US LLC, Astellas Pharma US, Inc. and Gilead Sciences, Inc.
Defendant:
Hikma Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HIKMA PHARMACEUTICALS USA, INC.
as 2:2021cv20459
Plaintiff:
CELGENE CORPORATION
Defendant:
HIKMA PHARMACEUTICALS USA, INC.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. HIKMA PHARMACEUTICALS USA, INC.
as 2:2021cv10398
Plaintiff:
CELGENE CORPORATION
Defendant:
HIKMA PHARMACEUTICALS USA, INC.
Cause Of Action: 35 U.S.C. § 271
CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC.
as 2:2021cv05034
Plaintiff:
CORCEPT THERAPEUTICS, INC.
Defendant:
HIKMA PHARMACEUTICALS USA INC.
Cause Of Action: 35 U.S.C. § 271
Hikma Pharmaceuticals USA Inc. et al v. Aurobindo Pharma Limited et al
as 1:2021cv00228
Plaintiff:
Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals LLC
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
